28-jun-2016
Merck has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop more robust, scalable vaccine manufacturing processes.
|
20160628 |
Medicamentos de molécula pequeña,Fabricación biofarmcéutica |